Toggle Dropdown
Groups
Announcements
Projects
Ideas
Welcome guest
Log in
Let's Practice
My Requests
All Requests
Drill Partners
Digital games
Projects
Goals
Loading
Loading...
Announcements
Projects
Orgs
Project
Articles 13
Votes 0
Cardiovascularbusiness.com
Home
Articles
What clinical research tells us about sotagliflozin and heart failure - Cardiovascular Business
almost3y
How CAD, PCI affect TAVR outcomes among men and women - Cardiovascular Business
almost3y
High-risk patients ineligible for bypass surgery see 'profound improvements' after PCI - Cardiovascular Business
almost3y
Heart palpitations, chest pain among the long-lasting side effects of COVID-19, new research confirms - Cardiovascular Business
almost3y
Severe gum infections linked to heightened AFib risk - Cardiovascular Business
almost3y
Cardiovascular disease still the No. 1 cause of death in the world - Cardiovascular Business
~3y
Treatments for rheumatoid arthritis, Parkinson's disease linked to cardiovascular benefits - Cardiovascular Business
~3y
Elon Musk and Eli Lilly: How a fake tweet caused chaos and reignited the debate over insulin prices - Cardiovascular Business
~3y
Diabetes patients are experiencing fewer heart attacks and strokes as patient care continues to evolve - Cardiovascular Business
~3y
VIDEO: Cardiac CT as a front-line chest pain exam in the ED - Cardiovascular Business
~3y
Can strength and endurance training help heart failure patients live longer? - Cardiovascular Business
>3y
Researchers receive $11.2M to study how the heart recovers from significant damage - Cardiovascular Business
>3y
Common heart medications linked to an increased heart attack risk in hot weather - Cardiovascular Business
>3y
Modal title
...
Profile
Loading profile
Loading...